5 ML levetiracetam 100 MG/ML Injection [Keppra] — RxCUI 647123
RxNorm drug concept · Semantic branded drug
RxCUI 647123
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI647123
Official name5 ML levetiracetam 100 MG/ML Injection [Keppra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as5 ML Keppra 100 MG/ML Injection; Keppra 500 MG in 5 ML Injection; Keppra 500 MG per 5 ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)903 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Levetiracetam is an anti-seizure medicine. Depending on the product and your age, it can be used to treat partial-onset seizures (seizures starting in one part of the brain), myocl...
- What is levetiracetam actually used for?
- It can, especially when you first start taking it. Drowsiness, fatigue, and dizziness are among the most common side effects and tend to be most noticeable in the first few weeks....
- Will levetiracetam make me feel tired or foggy?
🕸️ Concept Web — How 5 ML levetiracetam 100 MG/ML Injection [Keppra] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
5 ML levetiracetam 100 MG/ML Injection [Keppra]
RxCUI 647123 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Levetiracetam
114477IN
-
Levetiracetam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Keppra
261547BN
-
Keppra
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levetiracetam Injection
1790330SCDF -
Levetiracetam Injectable Product
1163449SCDG -
Levetiracetam Injection [Keppra]
1790332SBDF -
Keppra Injectable Product
1170052SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Levetiracetam Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
5 ML levetiracetam 100 MG/ML Injection
647121SCD -
Levetiracetam 100 MG/ML
406092SCDC -
Levetiracetam 100 MG/ML [Keppra]
576517SBDC
-
5 ML levetiracetam 100 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
5 ML levetiracetam 100 MG/ML Injection
SCD · 647121 -
Levetiracetam 100 MG/ML
SCDC · 406092 -
Levetiracetam Injection
SCDF · 1790330 -
Levetiracetam Injectable Product
SCDG · 1163449
Brand-Name Concepts
-
Levetiracetam 100 MG/ML [Keppra]
SBDC · 576517 -
Levetiracetam Injection [Keppra]
SBDF · 1790332 -
Keppra Injectable Product
SBDG · 1170052 -
Keppra
BN · 261547
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 647123 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50474-0002-63 | 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) / 5 mL in 1... | Keppra | UCB, Inc. | 2006-08-23 |
Observed labelers:
UCB, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1953 | Levetiracetam injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.